IFAM
PRTK

Institutional & Family Asset Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Institutional & Family Asset Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-325
Closed -$2K – 943
2020
Q3 		$2K Hold
325
– – ﹤0.01% 746
2020
Q2 		$2K Hold
325
– – ﹤0.01% 729
2020
Q1 		$1K Hold
325
– – ﹤0.01% 790
2019
Q4 		$1K Hold
325
– – ﹤0.01% 837
2019
Q3 		$1K Hold
325
– – ﹤0.01% 812
2019
Q2 		$1K Hold
325
– – ﹤0.01% 826
2019
Q1 		$2K Hold
325
– – ﹤0.01% 750
2018
Q4 		$2K Buy
+325
New +$2.47K ﹤0.01% 722

Other funds holding PRTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Institutional & Family Asset Management's PRTK Position: Q4 2020 in Review

Institutional & Family Asset Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q4 2020, closing a stake of 325 shares — an estimated $2K sold.

Institutional & Family Asset Management first reported a position in PRTK in Q4 2018 and held it in 8 quarters. The position peaked at $2K in Q3 2020. 108 funds tracked by Wall St. Rank hold PRTK as of Q4 2020.

  • Institutional & Family Asset Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Institutional & Family Asset Management sold 325 Paratek Pharmaceuticals, Inc. shares in Q4 2020, an estimated $2K.
  • Institutional & Family Asset Management first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2018 and held it in 8 quarters.
  • Institutional & Family Asset Management's Paratek Pharmaceuticals, Inc. position peaked at $2K in Q3 2020.
  • 108 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2020.

Based on Institutional & Family Asset Management's 13F filing for Q4 2020, filed 3 Feb 2021.